Research coauthored by RTI Health Solutions researchers will be presented at AMCP Nexus 2022.
Relative differences in brain volume loss with teriflunomide versus other disease-modifying therapies in relapsing multiple sclerosis: a systematic review and network meta-analysis. Ainsworth C, Higuchi K, Simou E, Guyot P, Araujo L, Greene N.
Shahnaz Khan, MPH, Vice President, Market Access and Outcomes Strategy at RTI Health Solutions will be attending as well. You can reach out to Evangelia or Shahnaz using the links below.
